期刊文献+

缬沙坦预适应在大鼠急性缺血再灌注中的心肌保护作用

The Study of Myocardial Protection and Its Mechanisms of Valsartan Preconditioning in the Ischemic and Reperfused Rat Hearts
下载PDF
导出
摘要 目的探讨缬沙坦预适应在大鼠心脏急性缺血再灌注中的心肌保护作用及机制。方法将40只SD大鼠随机分为5组(每组8只):模型对照组(C组),心梗对照组(M组),预适应后心梗组(I组),缬沙坦预适应组(AI组),缬沙坦心梗组(AM组)。2周后建立体内急性缺血再灌注心脏模型,监测缺血再灌注前后血中IL-6表达结果,以判断缬沙坦在预适应中的作用。结果缬沙坦预适应组较心梗组IL-6表达减少,与预适应组无统计学差异。结论缬沙坦预适应对体内大鼠心脏急性缺血再灌注时具有心脏保护作用。 Objective To investigate the protective effectof valsartan on the ischemic and reperfused rat myocardium and its mechanism. Methods Fourty Sprague-Dawley male rats were randomly and evenly divided into five groups:model control group; Ischemia-reperfusion group;Valsartan group treated with 5 nag valsartan per a kiogram once day. Rat models of I/R wew established with coronary occlusion 5 mintues and repeffusion 5 mintues of the left anterior descending artery after two - week's administration.At the end of repeffusion,the blood sample was taken and the plasma concentrations of IL- 6 were measured with enzyme - linked immunosorbent assay(ELISA) system.Results In comparison with model control group, the level of IL- 6 was decreased in valsartan group ( P 〈 0.05). Conclusion Valsartan may have the protective effect on the ischemic rat myocardium.
出处 《黑龙江医学》 2007年第5期343-344,共2页 Heilongjiang Medical Journal
关键词 缬沙坦 预适应 心肌保护 心肌再灌注损伤 Valsartan Preconditioning Myocardial protection Myocardial reperfusion injury
  • 相关文献

参考文献8

  • 1Lawson C S,Downey J M.Preconditioning:state of the art myocardial protein[J].Cardicvas Res,1994,27:542.
  • 2赵明中,陈运贞,李媛媛.大鼠心肌再灌注时心肌细胞凋亡、Fas基因表达及缺血预处理对其影响[J].中华内科杂志,1999,38(11):753-756. 被引量:32
  • 3Boli R.The late phase of preconditioning[J].Circ Res,2000,87:972~983.
  • 4吴伟康,尧宏斌,侯灿,罗汉川.四逆汤保护缺血心肌功能的实验研究[J].中国中医基础医学杂志,1995,1(3):24-26. 被引量:30
  • 5廖玉华,陶荣,程翔,童丹,胡燕,王敏,王朝晖.急性心肌梗死后心肌炎症反应及其意义[J].中国分子心脏病学杂志,2002,2(3):7-10. 被引量:40
  • 6Ikeda U,Ikeda M,Ohara T,et al.Interleukirr-6 stimulates the growth of vascular cells in PDGF depedent manner[J].Am J Physiol,1991,260:1713~1717.
  • 7Niimi R,Nakamura A,Yanagawa Y.Suppression of endotoxin-induced renal tumor necrosis factor-α and interleukin-6 mRNA by rennin-angiotensin ystem inhibitors[J].Jpn J Pharmacol,2000,86(2):139~145.
  • 8Araya J,Tsuruma T,Hirata K,et al.TCV-116,an angiotensin Ⅱ type Ⅰ receptor antagonist reduces hepatic ischemia-reperfusion injury in rats[J].Transplantation,2002,73(4):529~534.

二级参考文献3

共引文献99

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部